Avai Bio (AVAI) Enterprise Value (2019 - 2025)
Avai Bio's Enterprise Value history spans 6 years, with the latest figure at -$281.0 for Q1 2024.
- On a quarterly basis, Enterprise Value rose 99.74% to -$281.0 in Q1 2024 year-over-year; TTM through Mar 2024 was -$281.0, a 99.74% increase, with the full-year FY2024 number at -$281.0, up 99.74% from a year prior.
- Enterprise Value hit -$281.0 in Q1 2024 for Avai Bio, up from -$896.0 in the prior quarter.
- Over the last five years, Enterprise Value for AVAI hit a ceiling of -$281.0 in Q1 2024 and a floor of -$107472.0 in Q1 2023.
- Historically, Enterprise Value has averaged -$24023.9 across 5 years, with a median of -$17619.5 in 2020.
- Biggest five-year swings in Enterprise Value: crashed 26979.41% in 2020 and later soared 99.74% in 2024.
- Tracing AVAI's Enterprise Value over 5 years: stood at -$29514.0 in 2020, then tumbled by 104.53% to -$60364.0 in 2021, then surged by 68.84% to -$18812.0 in 2022, then surged by 95.24% to -$896.0 in 2023, then skyrocketed by 68.64% to -$281.0 in 2024.
- Business Quant data shows Enterprise Value for AVAI at -$281.0 in Q1 2024, -$896.0 in Q4 2023, and -$1480.0 in Q3 2023.